Why the study?
What are the safety guidelines and risks of device malfunction for patients with cardiac implantable electronic devices undergoing radiotherapy?
What are the safety guidelines and risks of device malfunction for patients with cardiac implantable electronic devices undergoing radiotherapy?
This document summarizes the 2017 Heart Rhythm Society guidelines on peri-radiotherapy care for patients with CIEDs to ensure safety and prevent device malfunction.
Supports vigilant CIED monitoring during high-energy RT; reinforces 2017 HRS consensus on energy-specific risks.
The number of patients with cardiac implantable electronic devices (CIED), who require oncological management including radiotherapy (RT) is still increasing. According to current knowledge the most frequent device dysfunction related to exposition to ionizing radiation is reprogramming to emergency mode (soft reset). There are uncommon cases of complete, irreversible device damage. CIED dysfunction during RT can be observed in approximately 3% of patients. In majority of cases they are asymptomatic, although in literature there are descriptions of deterioration of clinical status due to bradycardia or exacerbation of heart failure. The most important factor of device malfunction is radiotherapy with photons of energy >10 MV or protons despite energy used. So far there were no cases published with inadequate ICD therapies due to the presence of electromagnetic field interference during RT. Because patients with CIED undergoing RT need complex care to achieve high level of safety, experts of Heart Rhythm Society establish document, published in 2017 which summarized current knowledge about this group of patients. The document contains guidelines on peri-radiotherapy care of patients with CIED.
No takes yet. Share an insight, caveat, or question.
Chmielewska‐Michalak et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: